GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹5,967 Cr | ₹5,819 Cr | ₹4,546 Cr | ₹4,689 Cr | ₹4,201 Cr |
What is the latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹5,967 Cr |
| Mar2024 | ₹5,819 Cr |
| Mar2023 | ₹4,546 Cr |
| Mar2022 | ₹4,689 Cr |
| Mar2021 | ₹4,201 Cr |
How is Total Current Liabilities of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,967 Cr | 2.55 | |
| Mar2024 | ₹5,819 Cr | 27.99 | |
| Mar2023 | ₹4,546 Cr | -3.05 | |
| Mar2022 | ₹4,689 Cr | 11.63 | |
| Mar2021 | ₹4,201 Cr | - | |
Compare Total Current Liabilities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹57,453.1 Cr | -0.8% | 4.2% | 30.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.8% |
4.2% |
30.2% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses